Skip to content

Image Data Collection of Tanned Skin During Phototherapy Treatment Using a Multi-spectral Camera

Image Data Collection of Tanned Skin During Phototherapy Treatment Using a Multi-spectral Camera

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05692544
Enrollment
10
Registered
2023-01-20
Start date
2023-11-30
Completion date
2024-02-29
Last updated
2023-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lesion; Vascular, Pigment; Lesion

Brief summary

This is a prospective, observational, single-center, image collection study. Any patient who arrived at the phototherapy clinic for the first time, regardless of this study, and is prescribed a total of 30 treatments can be included, regardless of skin or medical condition. After consenting subjects at least 5 close-up images will be taken from the specified anatomical areas, at different angles, using the SMART camera. Additional reference images of skin that is not exposed to the phototherapy treatment will be taken with the SMART Camera. Global image of the skin using a regular high-resolution camera is optional. The images will be collected on baseline visit, at least every 3 phototherapy treatments (approximately once a week), and at the last phototherapy treatment visit. i.e., in total of at least 11 phototherapy treatment visits. Follow-up images will be taken at 1-week and 2 weeks following the last phototherapy treatment. Images shall be taken from any anatomical area that does not consist of any marked lesions or skin conditions. All images will be non-identifying.

Detailed description

The SMART camera is advanced proprietary multi-spectral system camera, developed for research purposes. The SMART camera system is based on commercially available components and consists of 3 modules: 1. Camera Handpiece- Spectral module with a monochromatic camera, optics, and an array of LEDs at 7 different wavelengths. 2. Control Unit - an electronic box that powers and controls the camera. It includes electronics and a miniature computer. 3. Touch screen monitor - With user interface to operate the system When taking a photo, a series of cross-polarized monochromatic images are taken, each at different illumination color (wavelength). In total, seven images are taken with blue (450nm), teal (490nm), lime (570nm), orange (590nm), red (660nm), IR-1 (730nm), IR-2 (860nm). The total acquisition time for the seven images is 0.1sec. The images are stored in a dedicated directory on a removable hard disk in the control unit in correlation to patient ID entered through the user interface on the laptop. The number of images that can be taken is unlimited. The camera passed the following safety tests by certified lab: 1. Check-up Safety Testing - IEC-60601-1 tests for investigational device by external laboratories according to IEC 60601-1, IEC 60601-2-22, IEC 60825-1, and IEC 60601-1-2 standards 2. LED Hazard Evaluation UV, Visible & NIR Test, according to IEC62471 by an external certified laboratory

Interventions

only patients was proscribe to phototherapy treatment can participate in the study

Sponsors

Lumenis Be Ltd.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Any patient, male or female 18 years or older. * Patient is scheduled for 30 treatments or more of phototherapy * Subject is capable and willing to sign an informed consent * Subject is willing to comply with study schedule * Subject has areas of skin that do not consist any marked lesions, hairs or skin conditions and can be captured in the study

Exclusion criteria

• Subjects incapable of providing an informed consent

Design outcomes

Primary

MeasureTime frameDescription
Image data4-monthsImages will be collected through the study

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026